Return to Diabetes Health

September 27, 2006

Actos Prevents Recurrent Heart Attacks

A new study has shown that diabetes drug Actos (pioglitazone) reduces the risk of recurrent heart attack in diabetics by 28 percent. While many were excited by the news, others were more cautious.

"This should draw attention to the use of pioglitazone, and it should get serious consideration, but it's a first, so it needs validation," said Dr. Robert H. Eckel, president of the American Heart Association. "One study should not make a paradigm for management."

Diabetes Drug Pulls Double Duty

Posted by Staff at 6:45 PM | Comments (0)


logo
Diabetes Health is part of the Health Diaries network. Health Diaries publishes blogs, articles, and news on health and fitness topics.

About
Advertise
Contact
Contribute
Sitemap


get well cards
Tell someone you're thinking of them with one of our free get well cards. We also have sympathy cards and blank cards if you want to send thanks or just a hello.
All content published on HealthDiaries.com is provided for informational and educational purposes only. HealthDiaries.com does not provide medical advice, diagnosis or treatment. The site and its services are not a substitute for professional medical advice and treatment. Always seek the advice of your doctor before making any changes to your diet, health routine or treatment.

Copyright © 2004-2007 HealthDiaries.com and the authors. All rights reserved.